Integrated Advisors Network’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,274
Closed -$954K 646
2022
Q2
$954K Sell
4,274
-1,278
-23% -$428K 0.06% 289
2022
Q1
$3.05M Buy
+5,552
New +$3.36M 0.18% 148
2021
Q4
Sell
-1,746
Closed -$1.47M 629
2021
Q3
$1.47M Buy
+1,746
New +$1.77M 0.1% 200

Other funds holding CDLX

Integrated Advisors Network's CDLX Position: Q3 2022 in Review

Integrated Advisors Network sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 4,274 shares — an estimated $954K sold.

Integrated Advisors Network first reported a position in CDLX in Q3 2021 and held it in 3 quarters. The position peaked at $3.05M in Q1 2022. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.

  • Integrated Advisors Network reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
  • Integrated Advisors Network sold 4,274 Cardlytics shares in Q3 2022, an estimated $954K.
  • Integrated Advisors Network first reported a position in Cardlytics in Q3 2021 and held it in 3 quarters.
  • Integrated Advisors Network's Cardlytics position peaked at $3.05M in Q1 2022.
  • 132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.

Based on Integrated Advisors Network's 13F filing for Q3 2022, filed 8 Nov 2022.